Human Recombinant Peptide Sponge Enables Novel, Less Invasive Cell Therapy for Ischemic Stroke

<div>Cell transplantation in the BMSC/scaffold group. Panels (a), (b), and (c) show photographs of the surgical treatment for cell transplantation in the BMSC/scaffold group. Panel (d) shows a brain removed 35 days posttransplantation in the BMSC/scaffold group. Arrows indicate the outer rim of the craniotomy (b), the RCP sponge with BMSCs (c), and remaining sponge (d).</div>

Stem Cells International

fig2

Figure 2

Figure 2: Human Recombinant Peptide Sponge Enables Novel, Less Invasive Cell Therapy for Ischemic Stroke 